An Open-Label, Multicentre, Long-term Extension Study of Tislelizumab-Containing Treatment and/or Pamiparib-Containing Treatment in Patients With Advanced Malignancies

Project: Research

StatusActive
Effective start/end date28/11/19 → 27/11/24
View all
View less

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • malignancy